Amount Raised
$7.5 Million
Round Type
Funding Round
DurhamBiotechnologyDescription
GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced the closing of an oversubscribed Series B1 financing, which raised $7.5 million.
Who else raised in Biotechnology around the same time
Companies in the same sectors as GeneCentric Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- EIP Pharma, Inc. raised $6M on December 23, 2021.
- Arcutis raised $225M (Debt Financing) on December 23, 2021.
- Appili Therapeutics Inc. raised an undisclosed amount (Funding Round) on December 22, 2021.
- MyndTec raised $79K on December 22, 2021.
- TandemAI raised $25M (Seed) on December 22, 2021.
- GATC HEALTH CORP raised $20K (Seed) on December 22, 2021.
Who to call at GeneCentric Therapeutics, and when
A new round usually means GeneCentric Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day GeneCentric Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GeneCentric Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GeneCentric Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GeneCentric Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
GeneCentric Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.